{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Promising Results for Advanced CML Patients Treated With Novel Three-Drug Combination

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the study methodology and patient population.
  2. Synthesize the study results at last follow-up in terms of regimen safety and effectiveness.

Learning Outcomes

By the conclusion of this activity, a majority of the participants will demonstrate knowledge of a study demonstrating the safety and promising activity of the combination of decitabine, venetoclax, and ponatinib for the treatment of patients with advanced phase chronic myeloid leukemia (CML) by achieving a passing score on the posttest.

Disclosures

The author and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: OT0125
Published: January 2025
Expires: 3/5/2027
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Catlin Nalley
Categories: Cancer , Chronic Myeloid Leukemia (CML) , Drug Therapy , Oncology
Specialties: Advanced Practice Nursing, Oncology
Topics: Cancer , Chemotherapy